BioSpace News Archive

Business

Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

Paragon 28, Inc. today announced a range of its preliminary unaudited revenue for the fourth quarter and full-year ended December 31, 2022.

January 10, 2023
·
3 min read
Business

GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook

GE HealthCare, a leader in precision care innovation, announced preliminary unaudited revenue results for the fourth quarter and full year 2022.

January 10, 2023
·
10 min read
Business

Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, announced today that significant progress has been achieved in its collaboration with Evotec SE (FSE: EVT; NASDAQ: EVO).

January 10, 2023
·
7 min read
Business

Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP

Amarin Corporation plc announced that Murray W. Stewart, D.M., F.R.C.P., has been appointed to the Company’s Board of Directors.

January 10, 2023
·
4 min read
FDA

Arthrex Receives FDA Clearance for TightRope® Implant as First, Only Device Cleared for Pediatric ACL Surgery

Arthrex announced today its ACL TightRope implant has received clearance from the U.S. Food and Drug Administration (FDA) for pediatric indications.

January 10, 2023
·
4 min read
Genetown

Instylla Announces Enrollment of Initial Patient in the Prospective Multicenter HALT Study

Instylla, Inc. today announced the enrollment of the first patient in the HALT Study1 for the treatment of peripheral arterial bleeds.

January 10, 2023
·
4 min read
European Association of Cardiovascular Imaging (EACVI) Collaborates With Surgical Science to Pilot the First Online Transesophagel Echo (TOE) Testing

The EACVI and Surgical Science have joined forces to create a unique TOE online simulator, aiming to evaluate TOE knowledge and performance level among young cardiologists and assess the need for simulation training for this purpose.

January 10, 2023
·
3 min read
Business

SIFI Announces License Agreement With Avanzanite Bioscience for Akantior®

SIFI announced that it has partnered with Avanzanite Bioscience, a Dutch specialty pharmaceutical company, to exclusively commercialize and distribute AKANTIOR® in 26 Countries within the European Economic Area and Switzerland.

January 10, 2023
·
5 min read
Policy

Dizal Announces China CDE Acceptance of New Drug Application for Sunvozertinib for Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations

Dizal announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted the New Drug Application for sunvozertinib for the treatment of advanced NSCLC with EGFR exon20ins mutations after platinum-based chemotherapies.

January 10, 2023
·
2 min read
Drug Development

Spago Nanomedical Publishes Scientific Paper on Positive Preclinical Data with Tumorad(R) as Treatment of Solid Tumors

Spago Nanomedical AB announced the publication of data on the composition, stability, and mode of action for its leading candidate drug 177Lu-SN201.

January 10, 2023
·
2 min read